Setareh van Driel Shamsili
Plus aucun poste en cours
Profil
Setareh van Driel Shamsili served as the Chief Medical Officer & Senior Vice President at Merus NV from 2012 to 2016.
He also worked as the Global Medical Leader-Oncology at Astellas Pharma Global Development, Inc. He later became the Chief Medical Officer at Ryvu Therapeutics SA from 2019 to 2022.
Dr. van Driel Shamsili holds a doctorate degree from Erasmus University Rotterdam and a graduate degree from Tehran University of Medical Sciences.
Anciens postes connus de Setareh van Driel Shamsili
| Sociétés | Poste | Fin |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Chief Tech/Sci/R&D Officer | 01/02/2022 |
| MERUS N.V. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Corporate Officer/Principal | - |
Formation de Setareh van Driel Shamsili
| Erasmus University Rotterdam | Doctorate Degree |
| Tehran University of Medical Sciences | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERUS N.V. | Health Technology |
| RYVU THERAPEUTICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma Global Development, Inc. provides business services. The company is headquartered in Deerfield, IL. | Health Technology |
